m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00156)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
H19
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | DKO-1 cell line | Homo sapiens |
Treatment: METTL3 knockdown DKO-1 cell
Control: DKO-1 cell
|
GSE182382 | |
Regulation |
|
logFC: -2.53E+00 p-value: 9.95E-11 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Either knockdown of METTL3 or METTL14 notably reversed the hypoxic preconditioning-induced enhancement of cell viability, anti-apoptosis ability, and H19 imprinted maternally expressed transcript (H19) expression. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Abnormalities of breathing | ICD-11: MD11 | ||
Cell Process | Cell viability | |||
Cell apoptosis | ||||
In-vitro Model | H9c2(2-1) | Normal | Rattus norvegicus | CVCL_0286 |
In-vivo Model | In vivo myocardial I/R injury was performed by 60 min of ligation of LAD followed by 5 h of reperfusion. | |||
Methyltransferase-like 14 (METTL14) [WRITER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Either knockdown of METTL3 or METTL14 notably reversed the hypoxic preconditioning-induced enhancement of cell viability, anti-apoptosis ability, and H19 imprinted maternally expressed transcript (H19) expression. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Abnormalities of breathing | ICD-11: MD11 | ||
Cell Process | Cell viability | |||
Cell apoptosis | ||||
In-vitro Model | H9c2(2-1) | Normal | Rattus norvegicus | CVCL_0286 |
In-vivo Model | In vivo myocardial I/R injury was performed by 60 min of ligation of LAD followed by 5 h of reperfusion. | |||
Abnormalities of breathing [ICD-11: MD11]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Either knockdown of METTL3 or METTL14 notably reversed the hypoxic preconditioning-induced enhancement of cell viability, anti-apoptosis ability, and H19 imprinted maternally expressed transcript (H19) expression. | |||
Responsed Disease | Abnormalities of breathing [ICD-11: MD11] | |||
Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell viability | |||
Cell apoptosis | ||||
In-vitro Model | H9c2(2-1) | Normal | Rattus norvegicus | CVCL_0286 |
In-vivo Model | In vivo myocardial I/R injury was performed by 60 min of ligation of LAD followed by 5 h of reperfusion. | |||
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Either knockdown of METTL3 or METTL14 notably reversed the hypoxic preconditioning-induced enhancement of cell viability, anti-apoptosis ability, and H19 imprinted maternally expressed transcript (H19) expression. | |||
Responsed Disease | Abnormalities of breathing [ICD-11: MD11] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell viability | |||
Cell apoptosis | ||||
In-vitro Model | H9c2(2-1) | Normal | Rattus norvegicus | CVCL_0286 |
In-vivo Model | In vivo myocardial I/R injury was performed by 60 min of ligation of LAD followed by 5 h of reperfusion. | |||